# LLM call: summary

- Turn: 11
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 877
- Completion tokens: 217
- Total tokens: 1094
- Cost (USD): 0.000131

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1615: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Through 2030 Shield stalemate persisted: Brussels offered no new money/chips, pushing lithography servicing tied to pooled compute and anchored builds in Japan/Korea/Singapore. Upstream Bargain stayed negotiation-paper with strait shut, no hardware moved. Anchorage Pact gave legal base only. Foreign-model medical therapies trialled in US hospitals then deployed via Brussels to a dozen certified cyber-recovered university centres, but dosing/variant-tuning depended on American cloud with reversions when queues stalled. Chinese robots on American software entered Rotterdam/Antwerp/Lodz logistics, cutting shifts, Lille pickets; Commission added only ENISA guides. US-leaving talent held chairs but queued on older EuroHPC nodes; cyber recovery partial, premiums up.

Early next year testable control/certification results from leading labs changed safety debate. With labs cooperating, AI Office and JRC issued certified harnesses for hospital dosing/variant-tuning models and segmentation checks for warehouse control software; procurement favoured passing models. Queue stalls and quiet reversions to US cloud fell; operators passed audits despite paperwork. Dependence unsolved: foreign frontier models, imported machines/software, strait still closed.

Ordinary offices reported measured AI productivity gains — juniors drafting faster, early cutters rehiring — blunting displacement fears, weakening union mobilisation beyond Lille and softening data-centre opposition. Tailored therapies moved into regular use in certified hospitals. Legitimacy rebuilt slightly; sovereignty did not.

CURRENT NARRATIVE:
### The cutoff
The notice arrived on a Friday with no reason attached. Clinicians in the dozen certified cancer centres found dosing and variant-tuning queries failing, ministry helpdesks and logistics planners locked out in the same hour. American frontier access, on which hospitals, firms and administrations had rebuilt, was withdrawn for European users.

Brussels had almost no fiscal room, but it had a playbook ready. Within weeks the Health Council ordered substitution: certified harnesses moved to older EuroHPC queues, stockpiled inference kept wards running, insurers were pressed to cover longer stays. Doctors kept treating, but slower, with older models and rationed queues. The reversions to the American cloud that audits had reduced returned as open failure.

### The leak that could not be recalled
In the same months a frontier-class open release spread to hundreds of thousands of machines in days. Whatever edge export controls and the strait closure had preserved vanished. At the same time a contested genome-model study claimed a non-expert could reach a human-infecting design with assistance. Specialists quarrelled over methods and over publication itself, while emergency screening on open genome use was added to the continuity reserve.

The reserve held the line visibly, and that mattered. Waiting lists in public hospitals that had adopted European triage tools kept falling, and ministers pointed to those numbers nightly. Offices still reported steady productivity gains, but coverage shifted to dependence: commentators called it humiliation, unions in logistics revived pickets, and trust in AI-mediated care dipped.

Gulf spare-capacity talk circulated among buyers as rumour — a broker mentioning paused domestic orders, a price sheet that never quite materialised — too faint to plan on.

The lithography mandate stayed frozen, Japanese and Korean hardware still unmoved. Europe kept running, on its own older machines.
```

## Raw response

```
Through 2030 Shield stalemate left Europe dependent on US frontier models/cloud and imported machines with strait closed; certified harnesses and EuroHPC queues reduced but did not solve dependence.

Then US frontier access was cut off without reason: certified cancer-centre dosing/variant-tuning, ministries and logistics locked out. Brussels ordered substitution to older EuroHPC queues and stockpiled inference; care continued slower with rationing, US-cloud reversions became open failure.

Simultaneously a frontier-class open release spread widely, erasing export-control edge, while a contested genome-model study warned non-experts could reach human-infecting designs; emergency screening added to continuity reserve. European triage kept waiting lists falling, offices kept productivity gains, but debate shifted to humiliation, logistics pickets revived, trust in AI care dipped. Gulf spare-capacity rumours too faint to plan on. Lithography mandate frozen, Japan/Korea hardware unmoved; Europe ran on older machines.
```
